Patidegib
About Patidegib
Services for the development of cancer therapy drugs are offered by Patidegib within the biotechnology sector. Focus is placed on oncology treatments through research and innovation processes. Leadership is provided by Alon Seri Levy as CEO, overseeing operations in drug discovery and clinical advancement. The company engages in pharmaceutical services aimed at therapeutic solutions, with activities conducted via its domain platform. No specific geographic details are noted for these operations.
-
Sectors
Healthcare
-
Phone
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Sol-Gel Technologies
(Jan 27, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Patidegib
Detailed funding history for Patidegib
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Patidegib
Patidegib has secured backing from 1 investor. Prominent investors backing the company include Sol-Gel Technologies.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Developing topical drug products for the treatment of rosacea, acne and interdigital tinea pedis.
|
Locked | Locked | Locked |
Investor details for Patidegib
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Patidegib
Investment portfolio details for Patidegib
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Patidegib
Detailed financials for Patidegib
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Patidegib Comparisons
Peer comparison for Patidegib
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Patidegib
Detailed competitors of Patidegib
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Patidegib
Complete news archive for Patidegib
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Patidegib
Alon Seri Levy is the current CEO of Patidegib.
Services for the development of cancer therapy drugs are offered by Patidegib within the biotechnology sector. Focus is placed on oncology treatments through research and innovation processes. Leadership is provided by Alon Seri Levy as CEO, overseeing operations in drug discovery and clinical advancement. The company engages in pharmaceutical services aimed at therapeutic solutions, with activities conducted via its domain platform. No specific geographic details are noted for these operations.
Patidegib has 1 investor. Key investors include Sol-Gel Technologies.